about
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersCharacterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patientsMucorales-Specific T Cells in Patients with Hematologic Malignancies.Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.Immunotherapy against EBV-lymphoma in recipients of HSCT.Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.European perspective on human polyomavirus infection, replication and disease in solid organ transplantation.Possible alternatives to antimicrobial therapies.De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation.Autologous human cytomegalovirus-specific cytotoxic T cells as rescue therapy for ulcerative enteritis in primary immunodeficiency.BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi.Persistent rhinovirus infection in pediatric hematopoietic stem cell transplant recipients with impaired cellular immunity.Identification of transcriptionally active HPV infection in formalin-fixed, paraffin-embedded biopsies of oropharyngeal carcinoma.Markers of squamocolumnar junction cells in normal tonsils and oropharyngeal cancer with and without HPV infection.Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.Biological individuality and the new frontiers of immunological tolerance in hematopoietic stem cell transplantation.T cell therapy for nasopharyngeal carcinoma.Conceiving a hematopoietic stem cell donor: twenty-five years after our decision to save a child.T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results.Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL.DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.Cell-based therapies: careful safety assessment for minimization of risk.Successful T-cell-depleted haploidentical hematopoietic stem cell transplantation in a child with dyskeratosis congenita after a fludarabine-based conditioning regimenPosttransplant Soluble B-Cell Activating Factor Kinetics in Pediatric Recipients of First Kidney AllograftHLA-Haploidentical T Cell–Depleted Allogeneic Hematopoietic Stem Cell Transplantation in Children with Fanconi AnemiaUnrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiencyArming CTLs against immunosuppressorsPolyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipientSerum complement inactivation unveiled prepregnancy donor-specific HLA antibodies leading to postpartum kidney graft lossDiscarded fraction from bone marrow erythrocyte depletion procedure is a good source of multipotent mesenchymal stromal cellsAcquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney RecipientsTreosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell diseaseTuberculosis-induced haemophagocytic syndrome in a patient on haemodialysis treated with anti-thymocyte globulin
P50
Q34166602-4FC2DF6D-7669-4E41-BBC1-7297C3E5941AQ34984670-DB2895CC-732E-443C-9F41-2445EC0723A4Q35922089-3F8F450D-827B-4CD2-8D5F-D17770D661FFQ37127201-2E46FB3B-8438-42B8-A851-72DFC0CDD395Q37345783-7650F7DC-7D49-48FC-8280-913759F24538Q37810283-A82D423B-2E5B-4569-AA59-058DC581FDB1Q38183114-820C5FB6-6F14-43F8-8B06-FB16BC635779Q38183118-56D5B824-00F7-4912-89DA-583489DCD1BBQ38202766-F01C08F8-B401-4C72-9EAF-6C821807CC9AQ38861456-AC7B028A-0933-46B0-8E00-07DBE7239013Q38930292-6D87F47C-74B7-4396-B71C-2A387058F4C5Q38989164-E32EDC7D-A714-419B-B4BB-BFA5F4870254Q39122060-47625E71-1DF9-4E28-BE4B-FDD40C3B7702Q40856883-C6D427D6-4E8B-46F4-8694-A187BB799FECQ40955845-03366B5C-3022-4243-80D2-76BFF135B9DBQ41468079-5D778CAA-3FC1-46CA-8495-EB84CCD5AE34Q41508319-EF13F169-5D1F-4FA0-A9E3-C5077C7BCBEEQ42273138-B8294CAB-9F5F-48A0-8932-F46B530A7BF7Q42434773-82C7136C-2891-46E5-8D7B-7A2F9CD40FFCQ42766336-FBF5A31E-2D02-4ED2-92A7-8DC211365569Q43166255-59AB0F39-7583-4046-96B5-4BBBF99862ADQ44267072-FB48D93E-9825-4F90-ACEF-35E6C37DABA4Q45972310-FAC71787-D07E-408E-A069-34ECCEC79469Q46446491-D2BCF770-CA08-4218-9585-E8327D08B9F7Q46938131-4EC4A60D-53C3-41D7-B2C2-FDA25FEBD461Q51791627-79686A9E-CC6F-402E-82A6-4218E5A0E8A8Q56970257-09F71042-4B53-4327-A04A-EBF450A4C070Q58620392-3C819FC2-6DAD-4E63-A725-6D6AA437CCBCQ61847198-76EBECFE-3CF9-49AE-A1AF-0F1C0B49A007Q82892057-1B9119F5-FC2F-47F0-AA56-F3C2FFBF05E7Q84990513-F5F8BDC7-EABA-4B3A-978E-8690D00A70F2Q85157571-EE3C86D0-0B96-4EB4-AAF8-66831B51E484Q86514232-529384BF-D5BD-4CE1-837F-256E00B850EDQ86673002-4C3DD0D7-9B60-4932-A171-958ADDE01327Q87006000-4C2E11EC-3467-49CA-8243-F33EAF782C29Q87011358-AF5C0A82-D8DF-4CF5-9545-63C7D1C603D3Q95810049-3BDFC045-EC68-47C5-9541-CD2216252DA1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Patrizia Comoli
@en
Patrizia Comoli
@nl
type
label
Patrizia Comoli
@en
Patrizia Comoli
@nl
prefLabel
Patrizia Comoli
@en
Patrizia Comoli
@nl
P31
P496
0000-0001-5964-0553